Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa

IMPORTANCE: Golimumab is a human monoclonal antibody, used for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Adverse reactions are increasing with this class of medication (tumor necrosis factor α inhibitors). OBSERVATIONS: The authors present a case of a female patient who p...

Descripción completa

Detalles Bibliográficos
Autores principales: Soto Lopes, Marien Siqueira, Trope, Beatriz Moritz, Rochedo Rodriguez, Maria Paula Rua, Grynszpan, Rachel Lima, Cuzzi, Tullia, Ramos-e-Silva, Marcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Published online: November, 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843912/
https://www.ncbi.nlm.nih.gov/pubmed/24348382
http://dx.doi.org/10.1159/000350930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843912/
https://www.ncbi.nlm.nih.gov/pubmed/24348382
http://dx.doi.org/10.1159/000350930

Ejemplares similares